Simplex Trading
KURA icon

Simplex Trading’s Kura Oncology KURA Stock Holding History

Simplex Trading’s Portfolio KURA Stock Details KURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$437K Sell
53,800
-2,900
-5% -$24.9K ﹤0.01% 3425
2025
Q4 		$589K Buy
56,700
+40,100
+242% +$421K ﹤0.01% 3141
2025
Q3 		$146K Buy
16,600
+15,600
+1,560% +$111K ﹤0.01% 5308
2025
Q2 		$5K Buy
1,000
+200
+25% +$1.23K ﹤0.01% 7746
2025
Q1 		$5K Sell
800
-8,500
-91% -$66.2K ﹤0.01% 7560
2024
Q4 		$81K Buy
9,300
+6,200
+200% +$89.2K ﹤0.01% 5383
2024
Q3 		$60K Buy
3,100
+300
+11% +$6.08K ﹤0.01% 5726
2024
Q2 		$57K Sell
2,800
-4,700
-63% -$96.6K ﹤0.01% 5949
2024
Q1 		$159K Buy
7,500
+6,200
+477% +$121K ﹤0.01% 5091
2023
Q4 		$18K Hold
1,300
– – ﹤0.01% 7005
2023
Q3 		$11K Buy
+1,300
New +$13.2K ﹤0.01% 7112
2023
Q2 		– Sell
-200
Closed -$2K – 9484
2023
Q1 		$2K Sell
200
-6,200
-97% -$77.4K ﹤0.01% 8475
2022
Q4 		$79K Sell
6,400
-12,900
-67% -$188K ﹤0.01% 5355
2022
Q3 		$263K Buy
19,300
+18,800
+3,760% +$290K ﹤0.01% 4258
2022
Q2 		$9K Hold
500
– – ﹤0.01% 8368
2022
Q1 		$8K Sell
500
-14,800
-97% -$214K ﹤0.01% 9069
2021
Q4 		$214K Sell
15,300
-8,300
-35% -$134K ﹤0.01% 5087
2021
Q3 		$512K Hold
23,600
– – ﹤0.01% 4076
2021
Q2 		$492K Buy
23,600
+23,522
+30,156% +$584K ﹤0.01% 4197
2021
Q1 		$220K Sell
78
-118
-60% -$3.73K ﹤0.01% 4607
2020
Q4 		$640K Sell
196
-209
-52% -$7.34K ﹤0.01% 3112
2020
Q3 		$1.24M Sell
405
-181
-31% -$4K ﹤0.01% 1989
2020
Q2 		$955K Buy
586
+550
+1,528% +$7.93K ﹤0.01% 2188
2020
Q1 		$35K Sell
36
-5
-12% -$57 ﹤0.01% 5487
2019
Q4 		$56K Buy
41
+14
+52% +$207 ﹤0.01% 5086
2019
Q3 		$40K Buy
27
+17
+170% +$303 ﹤0.01% 5231
2019
Q2 		$19K Buy
10
+9
+900% +$149 ﹤0.01% 5642
2019
Q1 		$1K Sell
1
-13
-93% -$200 ﹤0.01% 6911
2018
Q4 		$19K Hold
14
– – ﹤0.01% 5371
2018
Q3 		$24K Buy
14
+13
+1,300% +$249 ﹤0.01% 5813
2018
Q2 		$1K Sell
1
-14
-93% -$237 ﹤0.01% 7157
2018
Q1 		$9K Buy
+15
New +$292 ﹤0.01% 4127

Other funds holding KURA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Simplex Trading's KURA Position: Q1 2026 in Review

Simplex Trading reduced its Kura Oncology (KURA) stake by 75% in Q1 2026, selling an estimated $182K and leaving 6,905 shares worth $56.1K. The position accounts for ﹤0.01% of the portfolio, ranked #5746.

Simplex Trading first reported a position in KURA in Q2 2018 and has held it in 20 quarters since. The position peaked at $1.29M in Q3 2025. 220 funds tracked by Wall St. Rank hold KURA as of Q1 2026.

  • Simplex Trading held 6,905 shares of Kura Oncology worth $56.1K as of Q1 2026.
  • Simplex Trading sold 21,158 Kura Oncology shares in Q1 2026, an estimated $182K.
  • Kura Oncology made up ﹤0.01% of Simplex Trading's portfolio in Q1 2026, its #5746 holding.
  • Simplex Trading first reported a position in Kura Oncology in Q2 2018 and has held it in 20 quarters since.
  • Simplex Trading's Kura Oncology position peaked at $1.29M in Q3 2025.
  • 220 funds tracked by Wall St. Rank held Kura Oncology as of Q1 2026.

Based on Simplex Trading's 13F filing for Q1 2026, filed 14 May 2026.